Heart Failure: Targeting miRNA pathology in heart disease.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Works matching IS 14741776 AND DT 2014 AND VI 13 AND IP 5
Results: 22
1
2
CDK inhibitors speed ahead.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 5, p. 323, doi. 10.1038/nrd4332
- Publication type:
- Article
3
Pharma firms pool and share cancer trial data.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 5, p. 323, doi. 10.1038/nrd4331
- Publication type:
- Article
4
IN BRIEF.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 5, p. 336
- Publication type:
- Article
5
Anti-inflammatory drugs: 'Fish'ing for regulators of inflammation.
- Published in:
- 2014
- By:
- Publication type:
- journal article
6
NIH overhauls psychiatric trial policy.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 5, p. 323, doi. 10.1038/nrd4330
- Publication type:
- Article
7
Recent patents related to Notch signalling.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 5, p. 327, doi. 10.1038/nrd4329
- Publication type:
- Article
8
IN THIS ISSUE.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 5, p. 315, doi. 10.1038/nrd4318
- Publication type:
- Article
9
Interleukin-21: a double-edged sword with therapeutic potential.
- Published in:
- 2014
- By:
- Publication type:
- journal article
10
R&D productivity: on the comeback trail.
- Published in:
- 2014
- By:
- Publication type:
- journal article
11
John P. A. Ioannidis.
- Published in:
- 2014
- Publication type:
- Interview
12
Targeting bromodomains: epigenetic readers of lysine acetylation.
- Published in:
- 2014
- By:
- Publication type:
- journal article
13
Proactively managing the risk of marketed drugs: experience with the EMA Pharmacovigilance Risk Assessment Committee.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 5, p. 395, doi. 10.1038/nrd3713-c1
- By:
- Publication type:
- Article
14
Target identification: Stopping β-cell death in diabetes.
- Published in:
- 2014
- By:
- Publication type:
- journal article
15
Antiviral drugs: Spanner in the works of filovirus infection.
- Published in:
- 2014
- By:
- Publication type:
- journal article
16
Therapeutic modulation of Notch signalling--are we there yet?
- Published in:
- 2014
- By:
- Publication type:
- journal article
17
18 months sliced off Celebrex's patent protection.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 5, p. 326, doi. 10.1038/nrd4328
- By:
- Publication type:
- Article
18
Anticancer drugs: A new weapon against metastatic melanoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
19
Trial watch: Personalized medicines in late-stage development.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 5, p. 324, doi. 10.1038/nrd4325
- By:
- Publication type:
- Article
20
Cancer charity sees success re-prioritizing industry's shelved compounds.
- Published in:
- 2014
- By:
- Publication type:
- journal article
21
Zinc-finger nucleases make the cut in HIV.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 5, p. 321, doi. 10.1038/nrd4316
- By:
- Publication type:
- Article
22
The risks of methodology aversion in drug regulation.
- Published in:
- 2014
- By:
- Publication type:
- journal article